about
Optical coherence tomography: a window into the mechanisms of multiple sclerosisThe impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trialsOptical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.Optical coherence tomography as a biomarker in multiple sclerosis.Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.Bedside tested ocular motor disorders in multiple sclerosis patients.The Video Head Impulse Test.Evaluation of Visual-Evoked Cerebral Metabolic Rate of Oxygen as a Diagnostic Marker in Multiple SclerosisRetinal architecture and mfERG: Optic nerve head component response characteristics in MSMitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Management of optic neuritis in Canada: survey of ophthalmologists and neurologists.Eye disorders in patients with multiple sclerosis: natural history and management.Oculomotor deficits in aryl hydrocarbon receptor null mouseTransgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammationSymptomatic therapy in multiple sclerosisBaseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritisOptical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritisDiffusion tensor imaging detected optic nerve injury correlates with decreased compound action potentials after murine retinal ischemia.Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum AnalysisContrast sensitivity, first-order motion and Initial ocular following in demyelinating optic neuropathyColor vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosisAlemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.An Evaluation of Training with an Auditory P300 Brain-Computer Interface for the Japanese Hiragana Syllabary.Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of IranUsing fast eye movements to study fatigue in multiple sclerosis.Impairment of Smooth Pursuit as a Marker of Early Multiple Sclerosis.Summary of eye examinations of 284 patients with multiple sclerosis.Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.Translational research in neurology and neuroscience 2010: multiple sclerosisThe limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.The use of fourth-generation optical coherence tomography in multiple sclerosis: a review.Sex disparities in neuro-ophthalmologic disorders.Treatment of acute optic neuritis and vision complaints in multiple sclerosis.Evaluating response to disease-modifying therapy in relapsing multiple sclerosis.Experimental models of neuromyelitis optica: current status, challenges and future directions.Ocular motor signatures of cognitive dysfunction in multiple sclerosis.Afferent visual pathways in multiple sclerosis: a review.Acquired pendular nystagmus.Analysis of multiple sclerosis patients with electrophysiological and structural tests.Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study.
P2860
Q24655514-D8C07E76-473D-464C-8179-0A555098C86BQ28741521-D566F43D-27AF-430D-ADF5-E760AAEDFC16Q30499517-C888BA26-D404-43B2-8E20-1FA7D626E06AQ30597564-D47CEEB1-874D-4CA6-AFAA-C62B850A1A20Q30649660-1C975A3B-E5E7-4936-8354-E213323A27DEQ33614309-0A8BAB80-69B4-452F-8B95-6D86EDB57B0BQ33780681-DA322C98-BC9E-4C4C-B2F3-FEF886D58193Q33831782-998A0312-460D-4B79-86A1-97D827911A10Q33927190-A49E1DC8-C1EF-4B9A-BE45-27C4170741D4Q34152110-BB569273-B7C3-4632-913F-E82CB8A5487BQ34369920-479058AD-B544-4FA3-BB2A-85672A541095Q34399820-E4D74A00-D094-47C9-A7FF-F44277AB89AEQ34542533-7F689DFB-8235-4969-8841-4D74CCDEC7D1Q34919012-DF592652-0C1E-40D4-B507-F4D03E2349D6Q35018446-B7968313-4849-4BE8-8C76-659A4D580A71Q35032107-D9442560-97DF-4291-9F4E-C736889FE0E9Q35762462-DCEA285F-A8B7-45C4-9102-0652EFE96AFDQ35797144-FAA9AA9B-17AF-47F4-8331-9FC480FFC2DEQ35883802-FF67E248-2D45-4A1C-84EE-A350B368D977Q36691516-83520763-D03E-4ED6-897E-01706744BE05Q36879374-861A114E-91F0-4C49-8B9B-1E2FA870A1D7Q37253834-A6CC68D4-1079-4465-BAF7-490B82823DBDQ37298636-1E725839-FCF4-4C2D-A83A-9404EBA7F376Q37311783-3799112A-F28E-4B62-A94B-CCB8120C68ECQ37337053-EFD62915-C7B6-409D-B6F9-B7E6926714DFQ37425118-41BBFB66-7958-4FC3-A0FA-749935B1487BQ37442187-A6A918C4-080E-420F-B85C-7C71216B40C6Q37536318-2E103730-D610-4F30-B84D-256E67936205Q37772026-A8B3AAD6-CA2B-41BD-8345-2C4F281C0C36Q37849770-202F6508-DF01-4B49-8299-98D3A6719C9BQ38060795-6C66E2C9-F776-4200-9810-4DBFB5E1D8C7Q38218704-207E7F03-4E24-47AA-ABC6-E009F7D9E8F9Q38268540-44A68262-21C5-45B3-B05D-F7C0224A9C84Q38375605-D231B462-27A4-4336-BC29-D3DD05553F5DQ38537409-8565B71D-F295-4449-B0D8-D2B53AC9CD92Q38586620-6D827741-907E-453C-991B-3B163DFD17FFQ38787395-D9BE4860-DFF6-442B-B1AD-1EE8196C657DQ39188370-33DFBEE2-5EDB-4495-A109-359A833619D7Q39476387-8718D485-0EB9-491E-AE58-E2972EF00FF3Q39845142-C769069B-E74A-412E-8A63-681276D82F0B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The neuro-ophthalmology of multiple sclerosis.
@ast
The neuro-ophthalmology of multiple sclerosis.
@en
type
label
The neuro-ophthalmology of multiple sclerosis.
@ast
The neuro-ophthalmology of multiple sclerosis.
@en
prefLabel
The neuro-ophthalmology of multiple sclerosis.
@ast
The neuro-ophthalmology of multiple sclerosis.
@en
P2093
P1433
P1476
The neuro-ophthalmology of multiple sclerosis.
@en
P2093
David S Zee
Elliot M Frohman
Roderick McColl
Teresa C Frohman
P304
P356
10.1016/S1474-4422(05)00992-0
P577
2005-02-01T00:00:00Z